Management of Hypotension with Low Diastolic Blood Pressure

Understanding Hydralazine's Role and Risks

• Hydralazine is a direct-acting vasodilator that causes significant blood pressure reduction with effects beginning within 10-30 minutes and lasting 2-4 hours 1
• Hydralazine is associated with sodium and water retention, reflex tachycardia, and at higher doses can cause drug-induced lupus-like syndrome 3
• It is classified as a "secondary agent" in hypertension management, not a first-line medication 3

Clinical Decision Making for Low DBP

• A diastolic blood pressure of 47 mmHg is significantly below normal range and indicates the patient is already hypotensive 1, 2
• The American College of Cardiology guidelines recommend withholding scheduled hydralazine and monitoring blood pressure when diastolic readings are below 60 mmHg 2

Appropriate Management Approach

• For a patient with DBP of 47 mmHg, hold any scheduled hydralazine doses and monitor vital signs closely for trends 1, 2
• Evaluate for causes of hypotension (volume depletion, medication effects, cardiac issues) 2
• Consider fluid resuscitation if the patient is symptomatic from hypotension 1

Indications for Hydralazine Use

• Hydralazine is indicated for resistant hypertension as a step 5 agent 3, 1
• Hydralazine is indicated for hypertensive emergencies when administered intravenously 1
• Hydralazine is indicated in combination with isosorbide dinitrate for heart failure with reduced ejection fraction, particularly in African American patients 4, 5

Monitoring and Follow-up

• If the patient is on scheduled hydralazine for another indication, consult with the prescribing physician about temporarily holding the dose 1
• Continue to monitor blood pressure and reassess the need for antihypertensive therapy when both systolic and diastolic pressures return to appropriate levels 2